Manganese superoxide dismutase as a target of autoantibodies in acute Epstein-Barr virus infection

23Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Antibodies directed against the autoantigen p26 were detected in sera from 32 patients with acute Epstein-Barr virus (EBV) infection and clinical symptoms of infectious mononucleosis. P26 has now been identified as the enzyme manganese superoxide dismutase (MnSOD) by comparison of the NH2- terminal amino acid sequence. Antibodies against MnSOD belong to the immunoglobulin class M. They are not detectable in sera of patients with other herpesvirus infections. In the 32 patients investigated, the rise and fall of the autoantibodies coincides with the clinical symptoms. In vitro, the autoantibodies were shown to inhibit the dismutation of superoxide radicals by blocking MnSOD. As presented in the discussion this effect may contribute to the pathogenesis of acute EBV infection.

Cite

CITATION STYLE

APA

Ritter, K., Kühl, R. J., Semrau, F., Eiffert, H., Kratzin, H. D., & Thomssen, R. (1994). Manganese superoxide dismutase as a target of autoantibodies in acute Epstein-Barr virus infection. Journal of Experimental Medicine, 180(5), 1995–1998. https://doi.org/10.1084/jem.180.5.1995

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free